Pedro A Carrillo

Title: The Innovative Contributions of Pedro A. Carrillo

Introduction

Pedro A. Carrillo is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly through his innovative patents. With a total of 3 patents, Carrillo's work focuses on enhancing the efficacy of therapeutic agents.

Latest Patents

One of Carrillo's latest patents is centered around polypeptide fusions to polypeptides of the beta-trefoil fold structural. This invention is directed to the use of IL-1-like fusion polypeptides to increase the solubility and activity of recombinant polypeptides. It includes a nucleic acid encoding a fusion polypeptide comprising an interleukin-1-like polypeptide and a polypeptide of interest, along with the method of using such a nucleic acid to produce recombinant fusion polypeptides. Another significant patent involves the uses of TGF-β receptor fragment as a therapeutic agent. This patent discloses a method of treating TGF-β excess through parenteral, oral, or topical administration of TGF-β receptor fragment. Particularly effective is a soluble receptor fragment that resembles the extracellular portion of TGF-β binding protein II.

Career Highlights

Throughout his career, Carrillo has worked with various companies, including Celtrix Pharmaceuticals, Inc. His experience in the biotechnology sector has allowed him to develop groundbreaking solutions that address critical health issues.

Collaborations

Carrillo has collaborated with notable professionals in his field, including David R. Olsen and Desmond D. Mascarenhas. These collaborations have further enriched his research and development efforts.

Conclusion

Pedro A. Carrillo's innovative work in biotechnology has led to significant advancements in therapeutic applications. His patents reflect a commitment to improving health outcomes through scientific innovation.